“I recently read the press release dated 12/9/2008 in which Semmelweis endorses scientist’ call for Science to RETRACT fraudulent reports on HIV. I also read the letter sent to Science sent in Dec. 2008. I am new to this topic I didn’t know it was all based upon a fraud that has maintained for 30 years and I totally support the request to withdraw all the fraudulent papers from the journal. Nonetheless, up to this date, has it been any response to that letter from Science? Is it ever expected?” Continue reading ‘Lip Service – but No Word from Science Editors’
Archive for the 'Pharmaceutical' Category
20 Nov-New York – After a fifteen-month delay, the Supreme Court of the State of New York has made a decision in the case of Farber v. Jefferys, Kuritzky & Murtagh. Continue reading ‘Judge Denies Motion to Dismiss Farber Libel Suit: Case Continues’
20 Oct – The Ohio medical board concluded that pain physician William D. Leak had performed “unnecessary” nerve tests on 20 patients and subjected some to “an excessive number of invasive procedures,” including injections of agents that destroy nerve tissue. Yet the finding, posted on the board’s public website, didn’t prevent Eli Lilly and Co. from using him Continue reading ‘Disgraced Docs Push Drugs for Big Pharma’
May 21 Wash DC: Next week, the Government Accountability Project (GAP) will host the 2010 Whistleblower Assembly in Washington DC. According to their latest release, the event is co-sponsored by Semmelweis Society International (SSI) – this despite receiving proof that their alleged connection to SSI is a pharmaceutically-funded fraud. Continue reading ‘Corruption Threatens DC Whistleblowers’
In December 2007, Merkuri Stanback entered the Park Community Federal Credit Union in Macon, Georgia brandishing a firearm. Stanback and his cohorts restrained employees and ransacked the teller area before making off with almost $200K. When Stanback was arrested, a prosecutor declared that “bank robbers should be put on notice that they will serve the full term of years imposed because there is no parole in the federal system.” Continue reading ‘Carrots, Sticks & Useful Idiots’
The word is chutzpa – and it’s hard to imagine a better way to describe UC Berkeley (UCB) Vice Provost Sheldon Zedeck’s assignment of Arthur Reingold to investigate misconduct allegations against Professor Peter Duesberg, PhD. The charges stem from Duesberg’s (et al) report that was published in 2009 by Medical Hypotheses. Citing 35 references that includes South Africa’s (SA) own mortality reports, Prof. Duesberg’s team concluded that: Continue reading ‘The Berkeley Inquisition Exposed’
It began in 2009 with Eneydi Torres. Accused of exposing several men to HIV, Florida prosecutors threatened Torres with decades in prison unless she accepted their plea deal. But when asked to prove the reliability of HIV testing, prosecutors abruptly reduced their offer of 15 years in state prison to five days of unsupervised probation. Continue reading ‘Criminal HIV Trials Worry Pharma Execs’
Her mother’s murder trial has been over for a couple of weeks now, but I’m still haunted by little Rebecca Riley. Why did no one manage to rescue this 4-year-old child as her parents pumped her full of powerful psychotropic drugs, drugs that would kill her? And how could the doctor who blithely prescribed those drugs have escaped even the slightest penalty? Continue reading ‘What Killed Rebecca Riley’
It’s being called the largest research fraud in medical history. Dr. Scott Reuben, a former member of Pfizer’s speakers’ bureau, has agreed to plead guilty to faking dozens of research studies that were published in medical journals. Now being reported across the mainstream media is the fact that Dr. Reuben accepted a $75,000 grant from Pfizer to study Celebrex in 2005. Continue reading ‘Pharma Researcher Pleads Guilty for Faked Reports’
Dr. Ossi came to the hastily arranged gathering of health officials and academics expecting to talk to them about his company’s research into anti-viral drugs and flu vaccine. But the health experts clustered around a handful of tables were not interested in hearing about the science behind such products. They had much more pressing concerns. Continue reading ‘How Vaccines Became Big Business’